Objective: To review the impact of mindfulness-based stress reduction (MBSR) on symptoms of anxiety and depression in a range of clinical populations.
M ood and anxiety disorders are among the most common psychiatric disorders in Canada and are frequently comorbid with other mental and medical disorders. 1, 2 Despite the growing availability of effective pharmacotherapies and psychotherapies specific to anxiety and depressive disorders, 3, 4 innovative conceptual and therapeutic models of care continue to emerge that may be relevant to the amelioration of anxiety and depression in a broad range of medical and emotional disorders. MBSR, in particular, has emerged as one of the better-known clinical applications of mindfulness meditation, 5, 6 that has been shown to significantly benefit individuals with a diverse set of medical and psychiatric conditions, including chronic pain, 5 cancer, 7 anxiety disorders, 8 depression, 9 eating disorders, 10 and fibromyalgia. 11 (Kabat-Zinn defines mindfulness as the "awareness that emerges through paying attention on purpose, in the present moment, and nonjudgmentally to the unfolding of experience moment by moment." 12, p 145 ) The reduction of depression and anxiety symptoms after MBSR may be a primary pathway by which an individual experiences enhanced mental and physical health (for example, through less pain, reduced disability, or greater hope and confidence) and thus may be an important indicator of the efficacy of MBSR, given the often chronic and recurrent nature of many of the medical conditions (such as cancer) with which MBSR participants present.
Persistent symptoms of depression and anxiety possibly reflect deficiencies in coping that MBSR may be able to improve. Segal and colleagues 9 have defined the core mindfulness skill as the capacity to respond to aversive cognitions, sensations, and emotions with an attitude of nonjudgmental, accepting, present-moment awareness. The ability to recognize and disengage from dysfunctional thinking patterns (that is, process focus) associated with chronic medical and emotional disorders is a defining feature of mindfulness that is in contrast to approaches that attempt to change specific beliefs (content focus), common within traditional psychotherapies. Salmon and associates have summarized mindfulness practices as the (a) conscious allocation of attention in the service of (b) non-judgmental awareness; ideally cultivated (but not necessarily limited to) a state of (c) physiological hypo-arousal; with the intention of (d) enhancing present-moment awareness and (e) diminishing habitual patterns of cognitive, behavioral and physiological reactivity. 13, p 436 Thus regular mindfulness practice may produce improvements in mood and anxiety symptoms by reducing the tendency to react to negative mental and physical states with ruminative thought or maladaptive behaviour (for example, phobic behaviour or impulsivity). Individuals suffering from anxiety disorders may misconstrue experiences that others may judge as normative in such a way as to elicit intense feelings of panic and fear. Individuals suffering from depression may hold their negative self-perceptions with excessive conviction. Sustained mindfulness practice, through its repeated return of conscious awareness to the breath or the immediate present, interrupts the anxiogenic or depressogenic thought patterns that would otherwise increase the probability of maladaptive behaviours (such as phobic behaviour, social withdrawal, substance abuse, and suicidality. 14, 15 Salmon et al 13 argued that mindfulness meditation may lead to the detection of early signs of stress, ruminative thought, and physiological arousal and thereby afford the individual an opportunity to respond with more effective coping responses.
The goal of this article is to review the empirical evidence for the effectiveness of mindfulness meditation on symptoms of mood and anxiety in a wide range of clinical populations.
Method
Through a literature search conducted on MEDLINE, we identified controlled studies that administered MBSR to a clinical (that is, medical or psychiatric) population, including those adopting a waiting list or no-treatment control group and published in peer-reviewed journals. Although most studies randomized participants, we also included studies that adopted a quasi-experimental or convenience comparison sample. We reviewed each study for basic descriptive variables (sample size, clinical population, and age), measures of depression or anxiety, depression or anxiety outcomes, adherence to MBSR practice recommendations, follow-up, and modifications to the standard MBSR program.
Results
We identified 15 studies, 7, 11, [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] which are summarized in Table 1 . Diversity in the subject samples and methodologies (for example, sample size, control group, follow-up, randomization, and assessment methods) was evident. Only 4 studies 19, 26, 27, 29 explicitly treated individuals with mood disorders, while the remainder included populations with medical conditions (such as pain, cancer, and heart disease) or nonclinical populations (such as community samples and undergraduates). Program adherence and follow-up data were relatively
Does Mindfulness Meditation Improve Anxiety and Mood Symptoms? A Review of the Controlled Research
The infrequent. The most frequent measures of depression and anxiety were the SCL-90, the STAI, and the BDI. Table 2 summarizes the key findings contained in Table 1 . About one-half (8/15) of the studies reported a statistically significant reduction in anxiety or depression after MBSR. Unfortunately, none of these studies included an active control group. In other words, the positive findings were only found when waiting list or treatment-as-usual groups were used as control subjects. In the 2 studies that explicitly evaluated mindfulness-based cognitive therapy, 19, 26 which is an adaptation of MBSR for the prevention of depressive relapse, a role for mindfulness was found as a relapse-preventive approach. In the 2 studies that did use an active control group (subjects undergoing light treatment for psoriasis or psychotherapy outpatients), 18, 29 the MBSR intervention did not show a significant group or interaction effect on symptoms of depression and anxiety. With 8 of the 15 studies adopting a waiting list control group, it is not possible to attribute the reduction of symptoms of depression and anxiety to MBSR per se, since a comparable intervention or nonspecific factors also might have produced the observed benefits. The durability of the outcomes is also difficult to evaluate because only 6 studies reported follow-up data.
Six studies reported data measuring the practice of mindfulness by program attendees ( Table 2) . Three of these studies investigated the relation between mindfulness practice and reduction in anxiety and depression symptoms. Speca and colleagues 7 found that the number of minutes meditated daily explained 15.5% of the variance in mood improvement as measured by the POMS. Astin, 16 however, found the amount of time practising mindfulness skills did not correlate with the change in SCL-90-R scores. Mixed results were reported by Ramel and associates, 27 who found that the amount of time meditating did not predict follow-up anxiety and depression symptoms or DAS scores after controlling for baseline values; however, the amount of time meditating did significantly predict rumination. Little is known about how much subjects actually practised the core mindfulness skills that were taught. studied. The most common difference was the exclusion of the day-long retreat advocated by Kabat-Zinn. 5 This modification would reduce by up to 8 hours any additional training and practice in mindfulness. Other changes included variability in the recommended length of time for daily meditation (ranging from 20 to 60 minutes) and the inclusion of additional components and exercises that were unique to a specific study (such as loving-kindness, stress management, exercises, and readings). It is difficult to evaluate the impact of these program changes on the changes in anxiety and depression because the results of studies that most closely adhered to the MBSR model did not differ from those of the modified interventions.
Conclusion
On the basis of this overview's results, MBSR appears to have equivocal effects on symptoms of anxiety and depression. The benefits of MBSR were most evident when there was no active control group, suggesting that the symptomatic improvements might have been due to nonspecific variables rather than the effect of mindfulness intervention per se. Better controlled studies found no evidence for the efficacy of MBSR. Since the empirical evaluation of MBSR is relatively new, the adoption of waiting list control subjects may be justified in the effort to establish the effectiveness of MBSR. As this area of research matures, increased emphasis on research designs with active control groups will be necessary to assess the unique efficacy of this intervention. Symptoms of depression and anxiety may not ameliorate when they are not the explicit focus of an MBSR intervention (that is, when subjects with medical conditions are included). However, the risk for relapse after successfully treated depression does appear to be reduced by exposure to an MBSR-influenced intervention, suggesting that the benefits of this approach for alleviating anxiety and depression may be most evident when it is used as an adjunctive treatment rather than as the primary intervention. In a recent metaanalysis of mindfulness-based interventions 6 demonstrating a medium effect size (clustering around a coefficient of 0.50), only 1 of the 10 controlled studies included in that review was actually published, 7 in contrast to our study.
An issue that has yet to be adequately addressed is the extent and quality of the mindfulness practice during the intervention period. In this review, the few studies that actually did measure mindfulness practices and correlate them with outcomes did not find support for the amount of mindfulness practice, calling into question the role of mindfulness practice as the mechanism for the symptomatic improvements. To evaluate the unique efficacy of this intervention, researchers will need to ensure that their research design is able to validly measure the practice of mindfulness during and between treatment sessions.
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